SBI Securities’s Kazia Therapeutics KZIA Stock Holding History

SBI Securities’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100	Closed	-$627	–	4256
2025 Q2	$627	Buy	+100	New	+$467	﹤0.01%	2871

Other funds holding KZIA

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SBI Securities's KZIA Position: Q3 2025 in Review

SBI Securities sold out of Kazia Therapeutics (KZIA) in Q3 2025, closing a stake of 100 shares — an estimated $627 sold.

SBI Securities first reported a position in KZIA in Q2 2025 and held it in 1 quarter. The position peaked at $627 in Q2 2025. 11 funds tracked by Wall St. Rank hold KZIA as of Q3 2025.

SBI Securities reported no remaining Kazia Therapeutics position as of Q3 2025 after selling out during the quarter.
SBI Securities sold 100 Kazia Therapeutics shares in Q3 2025, an estimated $627.
SBI Securities first reported a position in Kazia Therapeutics in Q2 2025 and held it in 1 quarter.
SBI Securities's Kazia Therapeutics position peaked at $627 in Q2 2025.
11 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.